Dunelm Group plc ( OTCPK:DNLMY) Preliminary Q4 2025 Earnings Call September 9, 2025 4:30 AM EDT ...

ENDO 2025 featured the latest research on novel therapies for adrenal and neuroendocrine conditions, new data on various ...

PALO ALTO, Calif., Sept. 2, 2025 /PRNewswire/ -- Evommune, Inc., a clinical stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory ...

Analyze Fitbit usage data to uncover trends in activity and sleep, then translate insights into marketing strategies for Bellabeat’s Time watch.

Beta - This Python library is under active development. There may be breaking changes that occur until release of 0.1.0. The AI Data Science Team of Copilots includes Agents that specialize data ...

Final analysis of RATIONALE-315 demonstrates clear overall survival benefit in perioperative setting in resectable non-small cell lung cancer Broad EU label with nine approved indications in solid ...

New non-human primate (NHP) data for VLTR-559, a long-acting anti-VEGF therapy that could reduce the dosing frequency for the treatment of wet age-related macular degeneration (AMD) to twice-yearly, ...

LONDON and CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a ...